Home / Resource Library / RETREATMENT OF PATIENTS WITH REFRACTORY LARGE B CELL LYMPHOMA WITH AXICABTAGENE CILOLEUCEL (AXI-CEL) IN ZUMA-1

RETREATMENT OF PATIENTS WITH REFRACTORY LARGE B CELL LYMPHOMA WITH AXICABTAGENE CILOLEUCEL (AXI-CEL) IN ZUMA-1

EHA 2020: Results of a study examining the retreatment of CAR T therapy axicabtagene ciloleucel in treating large b-cell lymphomas.